S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.35%) $91.45

实时更新: Hypera S.A. [HYPMY]

交易所: OTC 部门: Healthcare 工业: Drug Manufacturers—Specialty & Generic
最后更新时间4 May 2024 @ 02:49

3.46% $ 5.94

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 02:49):

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands...

Stats
今日成交量 15 275.00
平均成交量 10 345.00
市值 3.76B
EPS $0.782 ( 2023-09-30 )
下一个收益日期 ( $0 ) 2024-07-25
Last Dividend $0.0640 ( 2023-07-06 )
Next Dividend $0 ( N/A )
P/E 11.64
ATR14 $0 (0.00%)

Hypera S.A. 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Hypera S.A. 财务报表

Annual 2023
营收: $7.91B
毛利润: $4.85B (61.30 %)
EPS: $2.61
FY 2023
营收: $7.91B
毛利润: $4.85B (61.30 %)
EPS: $2.61
FY 2022
营收: $7.55B
毛利润: $4.76B (63.10 %)
EPS: $2.68
FY 2021
营收: $5.94B
毛利润: $3.80B (64.05 %)
EPS: $2.11

Financial Reports:

No articles found.

Hypera S.A. Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.0590
(N/A)
$0.117
(N/A)
$0
(N/A)
$0.0590
(N/A)
$0.0640
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Hypera S.A. Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 9.59 - good (95.91%) | Divividend Growth Potential Score: 5.91 - Stable (18.26%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.0770 2011-05-10
Last Dividend $0.0640 2023-07-06
Next Dividend $0 N/A
Payout Date 2023-09-09
Next Payout Date N/A
# dividends 30 --
Total Paid Out $2.45 --
Avg. Dividend % Per Year 0.00% --
Score 4.13 --
Div. Sustainability Score 9.59
Div.Growth Potential Score 5.91
Div. Directional Score 7.75 --
Next Divdend (Est)
(2024-10-23)
$0.0654 Estimate 12.14 %
Dividend Stability
0.49 Below Average
Dividend Score
4.13
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
YOKEF Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
MALRY Ex Dividend Junior 2023-09-07 Annually 0 0.00%
CHRYY Ex Dividend Junior 2023-09-08 Annually 0 0.00%
SPKKY Ex Dividend Knight 2023-09-14 Annually 0 0.00%
GTPS Ex Dividend Knight 2023-09-14 Quarterly 0 0.00%
AGESY Ex Dividend Junior 2023-10-25 Annually 0 0.00%
NIDB Ex Dividend Knight 2023-08-10 Bi-Monthly 0 0.00%
CNTHO Ex Dividend Knight 2023-09-07 Quarterly 0 0.00%
TKAGY Ex Dividend Junior 2023-06-12 Annually 0 0.00%
HWDJY Ex Dividend Knight 2023-10-12 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.2121.5005.778.65[0 - 0.5]
returnOnAssetsTTM0.06041.2007.999.58[0 - 0.3]
returnOnEquityTTM0.1491.5009.4510.00[0.1 - 1]
payoutRatioTTM0.0801-1.0009.20-9.20[0 - 1]
currentRatioTTM1.8070.8005.974.77[1 - 3]
quickRatioTTM1.3140.8006.985.58[0.8 - 2.5]
cashRatioTTM0.6621.5007.4310.00[0.2 - 2]
debtRatioTTM0.378-1.5003.69-5.54[0 - 0.6]
interestCoverageTTM2.281.000-0.266-0.266[3 - 30]
operatingCashFlowPerShareTTM3.082.008.9710.00[0 - 30]
freeCashFlowPerShareTTM1.8662.009.0710.00[0 - 20]
debtEquityRatioTTM0.910-1.5006.36-9.54[0 - 2.5]
grossProfitMarginTTM0.6151.0003.093.09[0.2 - 0.8]
operatingProfitMarginTTM0.3271.0005.455.45[0.1 - 0.6]
cashFlowToDebtRatioTTM0.1831.000-0.0935-0.0935[0.2 - 2]
assetTurnoverTTM0.2860.800-1.429-1.143[0.5 - 2]
Total Score9.59

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM11.191.0008.970[1 - 100]
returnOnEquityTTM0.1492.509.6510.00[0.1 - 1.5]
freeCashFlowPerShareTTM1.8662.009.3810.00[0 - 30]
dividendYielPercentageTTM0.1781.5005.560[0 - 0.4]
operatingCashFlowPerShareTTM3.082.008.9710.00[0 - 30]
payoutRatioTTM0.08011.5009.20-9.20[0 - 1]
pegRatioTTM0.03941.500-3.070[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2431.0006.430[0.1 - 0.5]
Total Score5.91

Hypera S.A.

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company also provides dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo Química, Sodium Diclofenac, Hydroxyzine, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brand names. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. is based in São Paulo, Brazil.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。